Kestra Medical Technologies, Ltd.
KMTS
$15.38
-$1.12-6.79%
NASDAQ
04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
---|---|---|---|---|---|
Net Income | -113.81M | -84.05M | -84.16M | -89.14M | -94.12M |
Total Depreciation and Amortization | 7.97M | 9.63M | 11.11M | 11.33M | 11.56M |
Total Amortization of Deferred Charges | 1.40M | 1.23M | 1.26M | 934.00K | 610.00K |
Total Other Non-Cash Items | 33.04M | 4.86M | 4.70M | 5.27M | 5.83M |
Change in Net Operating Assets | -6.20M | -538.00K | 815.00K | 2.35M | 3.89M |
Cash from Operations | -77.61M | -68.86M | -66.27M | -69.25M | -72.24M |
Capital Expenditure | -23.59M | -19.75M | -20.65M | -16.58M | -12.51M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 283.00K | 42.00K | 45.00K | 165.00K | 285.00K |
Cash from Investing | -23.31M | -19.71M | -20.61M | -16.42M | -12.23M |
Total Debt Issued | -- | 0.00 | 0.00 | 22.50M | 45.00M |
Total Debt Repaid | -- | 0.00 | 0.00 | -19.56M | -39.12M |
Issuance of Common Stock | 218.16M | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | 103.40M | 115.90M | 128.40M | 101.70M | 75.00M |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 8.70M | 11.90M | 11.41M | 4.13M | -3.15M |
Cash from Financing | 330.26M | 127.80M | 139.81M | 108.77M | 77.73M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 229.35M | 39.23M | 52.93M | 23.10M | -6.74M |